Bone sarcoma incidence statistics

Cases

New cases of bone sarcoma, 2014, UK

 

Proportion of all cases

Percentage bone sarcoma is of total cancer cases, 2014, UK

 

Age

Peak rate of bone sarcoma cases, 2012-2014, UK

 

Trend over time

Bone sarcoma incidence rates have changed differently for each sex since the early 1990s, UK

Bone sarcoma accounts for less than 1% of all new cancer cases in the UK (2014). They account for less than 1% of the total in males, and less than 1% of the total in females.[1-4]

In 2014, there were 579 new cases of bone sarcoma in the UK: 305 (53%) in males and 274 (47%) in females, giving a male:female ratio of around 11:10.[1-4] The crude incidence rate Open a glossary item shows that there is 1 new case of bone sarcoma for every 100,000 males in the UK, and nearly 0.8 for every 100,000 females.

The European age-standardised incidence rates Open a glossary item (AS rates) do not differ significantly between the other constituent countries of the UK for either sex.[1-4]

Bone Sarcoma (C40-C41), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Countries of the UK, 2014

England Wales Scotland Northern Ireland UK
Male Cases 250 16 34 5 305
Crude Rate 0.9 1.1 1.3 0.6 1.0
AS Rate 1.0 1.1 1.3 0.5 1.0
AS Rate - 95% LCL 0.8 0.6 0.9 0.1 0.9
AS Rate - 95% UCL 1.1 1.7 1.7 1.0 1.1
Female Cases 222 13 28 11 274
Crude Rate 0.8 0.8 1.0 1.2 0.8
AS Rate 0.8 0.8 1.0 1.2 0.8
AS Rate - 95% LCL 0.7 0.4 0.6 0.5 0.7
AS Rate - 95% UCL 0.9 1.2 1.4 1.8 0.9
Persons Cases 472 29 62 16 579
Crude Rate 0.9 0.9 1.2 0.9 0.9
AS Rate 0.9 0.9 1.1 0.9 0.9
AS Rate - 95% LCL 0.8 0.6 0.9 0.4 0.8
AS Rate - 95% UCL 1.0 1.3 1.4 1.3 1.0

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

For bone sarcoma, like most cancer types, differences between countries largely reflect risk factor prevalence in years past.

References

  1. Data were provided by the Office for National Statistics on request, June 2016. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases.
  2. Data were provided by ISD Scotland on request, May 2016. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, June 2016. Similar data can be found here:  http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2016. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for: UK, 2014, ICD-10 C40-C41

Last reviewed:

Bone sarcoma incidence is related to age, with the first peak in incidence rates being in older children and teenagers, and the second peak in older males and females. In the UK in 2012-2014, on average each year more than half (53%) of cases were diagnosed in people aged 45 and over.[1-4]

Age-specific incidence rates rise sharply from birth and peak first in older children and teenagers. Rates then drop gradually until around age 35-39 and remain stable until age 45-, before rising steadily again, with the highest rates overall in the 90+ age group for males and 85-89 age group for females. Incidence rates are significantly higher for males than females in those aged 40-44 and over and this gap is widest at the ages of 80 to 84, when the male:female ratio of age-specific incidence rates (to account for the different proportions of males to females in each age group) is around 18:10.[1-4]

Bone Sarcoma (C40-C41), Average Number of New Cases per Year and Age-Specific Incidence Rates Per 100,000 Population, UK, 2012-2014

For bone sarcoma, like most cancer types, incidence increases with age. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors. A drop or plateau in incidence in the oldest age groups often indicates reduced diagnostic activity perhaps due to general ill health.

References

  1. Data were provided by the Office for National Statistics on request, June 2016. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases.
  2. Data were provided by ISD Scotland on request, May 2016. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, June 2016. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2016. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2012-2014, ICD-10 C40-C41

Last reviewed:

Bone sarcoma incidence rates have increased by 14% in the UK since the early 1990s.[1-3] This includes stable rates in males and an increase in females. Bone sarcoma incidence rates decreased by 13% (persons) in Great Britain between 1979-1981 and 1991-1993.[1-3]

For males, European age-standardised (AS) Open a glossary item incidence rates remained stable overall between 1993-1995 and 2012-2014. For females, rates increased between by 22% in this period.

Bone Sarcoma (C40-C41), European Age-Standardised Incidence Rates, By Sex, UK, 1993-2014

Over the last decade in the UK (between 2003-2005 and 2012-2014), bone sarcoma AS incidence rates have remained stable, for males and females separately and for both sexes combined.[1-3]

Bone sarcoma incidence rates have remained relatively stable in most broad age groups in UK since the early 1990s.[1-3] However, in people aged 25-49 and 50-59, European AS incidence rates increased by 41% and 50% respectively between 1993-1995 and 2012-2014. In the other age groups, rates have remained stable overall between 1993-1995 and 2012-2014, though in some there has been a significant decrease followed by an increase during this period.

Bone Sarcoma (C40-C41), European Age-Standardised Incidence Rates, by Age, UK, 1993-2014

For bone sarcoma, like most cancer types, incidence trends largely reflect changing prevalence of risk factors and improvements in diagnosis and data recording. Recent incidence trends are influenced by risk factor prevalence in years past, and trends by age group reflect risk factor exposure in birth cohorts.

References

  1. Data were provided by the Office for National Statistics on request, June 2016. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, May 2016. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/ 
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, June 2016. Similar data can be found here: http://www.wcisu.wales.nhs.uk
  4. Data were provided by the Northern Ireland Cancer Registry on request, May 2016. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/

About this data

Data is for UK, 1993-2014, ICD-10 C40-41

Last reviewed:

The largest proportion of bone sarcoma cases occur in the lower limb, with smaller proportions in the pelvic bones, and much smaller proportions in the upper limb and head (2010-2012).[1-4]

The proportion of cases in each part of the body is similar between males and females.[1-4]

A moderate proportion of cases did not have the specific location of the sarcoma recorded in cancer registry data, or overlapped more than one part.[1-4]

Cases and percentages may not sum due to rounding

References

  1. Data were provided by the Office for National Statistics on request, July 2014. Similar data can be found here:http://www.ons.gov.uk/ons/rel/vsob1/cancer-statistics-registrations--england--series-mb1-/index.html.
  2. Data were provided by ISD Scotland on request, April 2014. Similar data can be found here:http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit on request, April 2014. Similar data can be found here:http://www.wales.nhs.uk/sites3/page.cfm?orgid=242&pid=59080.
  4. Data were provided by the Northern Ireland Cancer Registry on request, June 2014. Similar data can be found here:http://www.qub.ac.uk/research-centres/nicr/CancerInformation/.
Last reviewed:

Bone sarcoma incidence rates are projected to fall by 5% in the UK between 2014 and 2035, to 1 case per 100,000 people by 2035.[1] This includes an increase for females and a drop for males.

For males, bone sarcoma European age-standardised (AS) Open a glossary item incidence rates in the UK are projected to fall by 31% between 2014 and 2035, to 1 case per 100,000 by 2035.[1] For females, rates are projected to rise by 24% between 2014 and 2035, to 1 case per 100,000 by 2035.[1]

Bone sarcoma (C40-C41), Observed and Projected Age-Standardised Incidence Rates, by Sex, UK, 1979-2035

 

It is projected that 568 cases of bone sarcoma (217 in males, 351 in females) will be diagnosed in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C40-C41

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as"increase" or "decrease" if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

The lifetime risk of developing bone sarcoma is around 1 in 1,140 for men and around 1 in 1,660 for women, in 2012 in the UK.[1]

The lifetime risk for bone sarcoma has been calculated on the assumption that the possibility of having more than one diagnosis of bone sarcoma over the course of a lifetime is very low (‘Current Probability’ method).[2]

References

  1. Lifetime risk estimates calculated by the Statistical Information Team at Cancer Research UK. Based on data provided by the Office of National Statistics, ISD Scotland, the Welsh Cancer Intelligence and Surveillance Unit and the Northern Ireland Cancer Registry, on request, December 2013 to July 2014.
  2. Esteve J, Benhamou E and Raymond L. Descriptive epidemiology. IARC Scientific Publications No.128, Lyon, International Agency for Research on Cancer, pp 67-68 1994.
Last reviewed:

There is no evidence for an association between bone sarcoma incidence and deprivation for either males or females in England.[1] England-wide data for 2006-2010 show European age standardised Open a glossary item incidence rates are similar for both males and females living in the most deprived areas compared with the least deprived.[1]

Bone Sarcoma (C40-C41), European Age-Standardised Incidence Rates by Deprivation Quintile, England, 2006-2010

The estimated deprivation gradient in bone sarcoma incidence between people living in the most and least deprived areas in England has not changed in the period 1996-2010.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for UK, 2006-2010, ICD-10 C40-C41

Deprivation gradient statistics were calculated using incidence data for 2006-2010. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 1.5 out of 5 based on 8 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page